创模生物科技(北京)有限公司

CN / En

NEWS

In Vitro Killing Experimental Platform from InnoModels Biotechnology

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-09-25 16:44
  • Views:

(Summary description)In the vast field of life science and drug discovery, in vitro experimental platforms play a crucial role. As a leader in this field, InnoModels Biotechnology (Beijing) Co., Ltd. provides scientists with a highly controlled and precise experimental environment with its in vitro killing platform, which greatly facilitates the screening of new drugs, the study of drug mechanisms, and the development of immunotherapies.

In Vitro Killing Experimental Platform from InnoModels Biotechnology

(Summary description)In the vast field of life science and drug discovery, in vitro experimental platforms play a crucial role. As a leader in this field, InnoModels Biotechnology (Beijing) Co., Ltd. provides scientists with a highly controlled and precise experimental environment with its in vitro killing platform, which greatly facilitates the screening of new drugs, the study of drug mechanisms, and the development of immunotherapies.

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-09-25 16:44
  • Views:
Information

In the vast field of life science and drug discovery, in vitro experimental platforms play a crucial role. As a leader in this field, InnoModels Biotechnology (Beijing) Co., Ltd. provides scientists with a highly controlled and precise experimental environment with its in vitro killing platform, which greatly facilitates the screening of new drugs, the study of drug mechanisms, and the development of immunotherapies.
Platform Overview
InnoModels' in vitro killing platform is a comprehensive experimental platform integrating multiple advanced technologies, focusing on simulating cell-cell interactions in an in vitro environment, especially the killing effect of immune cells on tumor cells. The platform ensures the accuracy and reproducibility of the experimental results by precisely controlling the experimental conditions, such as temperature, humidity and atmosphere. Meanwhile, it supports the application of multiple cell types, including tumor cells, primary cells, etc., providing researchers with a wide range of possibilities in different fields.
Platform Features
1. **Highly controllable experimental environment**: The in vitro killing experimental platform of InnoModels Biotechnology is able to precisely regulate the experimental conditions and reduce the interference of external factors to ensure the accuracy of the experimental results.
2. **Multiple cell types support**: The platform supports the application of multiple cell types, enabling researchers to carry out a wide range of studies in different fields and meet diversified experimental needs.
3. **Real-time monitoring and data analysis**: During the experiment, the platform is able to monitor the cell status and response in real-time, as well as record and analyze the data, providing researchers with comprehensive experimental results.
4. **Advanced automation technology**: Automation technology is used to optimize the experimental process, reduce experimental errors, and improve the reliability and efficiency of experiments.
Core Technology and Application
One of the core technologies of the platform is the PBMC-tumor cell co-culture killing model. The model achieves precise distinction between effector cells (immune cells) and target cells (tumor cells) by mixing cultured peripheral blood single nucleated cells (PBMCs) and tumor cells, and using CFSE-labeled tumor cells and CD45-labeled immune cells. The killing of target cells was verified by flow cytometry, which effectively reduces the influence of immune cell proliferation and apoptosis on the test results, and achieves an accurate assessment of killing.

 


Application Areas
The in vitro killing experimental platform of InnoModels Biotechnology has been widely used in many fields:
1. **Drug Screening**: Researchers can utilize the platform to conduct large-scale drug screening to assess the killing effect of drugs on cells, providing important data support for new drug discovery.
2. **Toxicity assessment**: It is used to assess the toxicity level of compounds or drugs, providing key information for safety assessment during drug development.
3. **Immunotherapy Research**: When researching immunotherapy, the platform can be used to assess the killing effect of immune cells on tumor cells, providing an important reference for the development and optimization of immunotherapy.
4. **Personalized Medicine**: Tailor-made treatment plans based on individual patient's immune response to improve therapeutic effects and promote the development of individualized medicine.
Company Background and Vision
Ltd. was co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Champion and Shanghai Jiao Tong University Institute of Immunology. The company has always been committed to promoting technological innovation and providing scientists with advanced experimental tools to help research and development of oncology and tumor immunotherapy. Its in vitro killing experimental platform, as one of the company's important achievements, not only provides strong support for drug discovery companies and translational medicine researchers, but also brings more therapeutic hope to tumor patients.
In the future, InnoModels Biotechnology will continue to uphold the attitude of never compromising on quality, adhere to the ethical bottom line of scientists, and dedicate itself to providing more advanced and reliable experimental platforms and technical support in the field of life science research and drug development, and promoting the continuous progress and development of the scientific field.

Keyword:

With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
In the vast field of drug discovery and life science research, InnoModels Biotechnology (Beijing) Co., Ltd. is gradually becoming a leader in the industry with its IC50 platform. The platform not only integrates advanced detection technologies, abundant cell resources and strict quality control system, but also provides researchers with efficient and reliable experimental solutions through continuous innovation and optimization.
In the field of life sciences, every leap in technology leads to deeper research and medical advances. InnoModels Biotechnology (Beijing) Co., Ltd, with its innovative 3D organoid platform, is providing scientists with an unprecedented research tool, which greatly promotes drug research and development and the exploration of disease mechanisms
In the vast starry sky of biomedical research, InnoModels Biotechnology (Beijing) Co., Ltd. is like a bright star, illuminating the journey of oncology and tumor immunology drug development with its unique PDX in vivo efficacy model. Today, let's go into InnoModels Biotechnology to learn more about its industry-leading PDX in vivo efficacy model and explore its unlimited potential in drug discovery and development.
Previous page
1
2
42
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司